• Aucun résultat trouvé

Supplementary Table

N/A
N/A
Info
Télécharger
Protected

Academic year: 2022

Partager "Supplementary Table"

Copied!
1
0
0

Chargement.... (Voir le texte intégral maintenant)

Texte intégral

(1)

Supplementary Table

Table S1

Negative Controls COVID-19 Patients

No (%) Median (IQR) Range No (%) Median (IQR) Range

Age (years)

All 326 (100) 33.4 (22.4) 1.0-89.5 181 (100) 53.1 (29.2) 20.1-86.9 0-17 50 (15.3)

18-40 165 (50.6) 61 (33.7)

41-65 86 (26.4) 70 (38.7)

66+ 25 (7.7) 50 (27.6)

Gender

Female 168 (51.5) 70 (38.7)

Male 158 (48.5) 111 (61.3)

Hospitalized 91 (50.3)

Outpatient 90 (49.7)

dpos/dpd

0-10 8 (4.4) 7.0 (1.75) 0-8

11-20 112 (61.9) 15.0 (2.0) 11-20

21-39 61 (33.7) 28.0 (5.0) 21-39

dpos days post onset of symptoms, dpd days post diagnosis, IQR inter quartile range

1 1

2

Références

Télécharger maintenant ( DOCX - 1 Page - 28.81 KB )

Documents relatifs

SUPPLEMENTARY MATERIALSupplementary Table 1. Hospital centers participating to the studyCountryCenterCRFsProven/probable IAIsolates

SUPPLEMENTARY MATERIAL. Supplementary

Supplementary Table 1A Sample Overview

Blue dots represent clonotypes that have a statistically significant greater frequency in sample A compared to sample B, red dots

APPENDIX 1 Supplementary Table Table S1.

Great Reed Warbler Acrocephalus arundinaceus Basra Reed Warbler Acrocephalus griseldis Upcher’s Warbler Hippolais languida Olive-tree Warbler Hippolais olivetorum Melodious

(1)Supplementary Table 1

[r]

Supplementary material. Table S1. Detailed description of included studies

Subjects who fulfilled DSM-III-R criteria for current dependence on another substance and those with a history of or current psychotic disorder unrelated to cocaine use were

Supplementary Table S1.

Risk of bias assessment for included RCTs.. Study

Supplementary Table 1. PRISMA checklistSection/topic #Checklist item Reported on page # TITLE

Structured summary 2 Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions;

Additional file 1. Supplementary Figure and Table Legends Figure S1

a Effect of 10mM metformin on viable cell number under 21% and 1% oxygen; b Effect of increasing concentrations of metformin on viable cell number of astrocytes under 21%, 5% and